LSV Asset Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

LSV Asset Management’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-232,400	Closed	-$9.59M	–	1004
2015 Q2	$9.59M	Buy	232,400 +73,094	+46%	+$2.62M	0.02%	390
2015 Q1	$5.61M	Buy	159,306 +65,706	+70%	+$2.22M	0.01%	470
2014 Q4	$3.01M	Hold	93,600	–	–	0.01%	546
2014 Q3	$2.63M	Sell	93,600 -109,600	-54%	-$3.34M	0.01%	562
2014 Q2	$6.14M	Sell	203,200 -70,402	-26%	-$1.94M	0.01%	433
2014 Q1	$7.57M	Sell	273,602 -4,700	-2%	-$123K	0.02%	403
2013 Q4	$7.11M	Buy	278,302 +23,244	+9%	+$716K	0.02%	413
2013 Q3	$7.62M	Buy	+255,058	New	+$7.09M	0.02%	383

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

LSV Asset Management's BRLI Position: Q3 2015 in Review

LSV Asset Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 232,400 shares — an estimated $9.59M sold.

LSV Asset Management first reported a position in BRLI in Q3 2013 and held it in 8 quarters. The position peaked at $9.59M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

LSV Asset Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
LSV Asset Management sold 232,400 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $9.59M.
LSV Asset Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q3 2013 and held it in 8 quarters.
LSV Asset Management's BIO-REFERENCE LABS INC-NEW- position peaked at $9.59M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on LSV Asset Management's 13F filing for Q3 2015, filed 5 Nov 2015.